H. B. Fuller (NYSE:FUL – Get Free Report) had its target price lifted by Citigroup from $67.00 to $70.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the specialty chemicals company’s stock. Citigroup’s target price points to a potential upside of 17.19% from the company’s current price.
A number of other equities research analysts have also issued reports on FUL. Vertical Research upgraded H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday. Weiss Ratings restated a “hold (c)” rating on shares of H. B. Fuller in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of H. B. Fuller in a research report on Friday, January 16th. Wall Street Zen raised shares of H. B. Fuller from a “hold” rating to a “buy” rating in a report on Sunday. Finally, UBS Group reduced their price target on shares of H. B. Fuller from $66.00 to $63.00 and set a “neutral” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $65.50.
Check Out Our Latest Analysis on H. B. Fuller
H. B. Fuller Trading Up 0.9%
H. B. Fuller (NYSE:FUL – Get Free Report) last released its quarterly earnings data on Wednesday, March 25th. The specialty chemicals company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.01. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The company had revenue of $770.84 million for the quarter, compared to the consensus estimate of $787.77 million. During the same period last year, the business posted $0.54 EPS. The company’s quarterly revenue was down 2.3% compared to the same quarter last year. Equities research analysts forecast that H. B. Fuller will post 4.07 EPS for the current fiscal year.
Institutional Trading of H. B. Fuller
Several hedge funds have recently bought and sold shares of FUL. Deprince Race & Zollo Inc. boosted its position in shares of H. B. Fuller by 80.4% during the third quarter. Deprince Race & Zollo Inc. now owns 555,877 shares of the specialty chemicals company’s stock worth $32,952,000 after buying an additional 247,815 shares during the period. New York State Common Retirement Fund grew its stake in shares of H. B. Fuller by 38.3% in the third quarter. New York State Common Retirement Fund now owns 149,448 shares of the specialty chemicals company’s stock worth $8,859,000 after purchasing an additional 41,365 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of H. B. Fuller by 16.2% in the second quarter. JPMorgan Chase & Co. now owns 612,048 shares of the specialty chemicals company’s stock worth $36,815,000 after purchasing an additional 85,469 shares in the last quarter. Squarepoint Ops LLC bought a new stake in shares of H. B. Fuller during the second quarter valued at about $1,661,000. Finally, Luminus Management LLC bought a new stake in shares of H. B. Fuller during the 3rd quarter worth about $2,172,000. 95.93% of the stock is currently owned by institutional investors.
H. B. Fuller Company Profile
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Featured Stories
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
